124 related articles for article (PubMed ID: 25341342)
1. [Expression and clinical signification of IL-10 and IL-17 in endometrial cancer].
Li L; Cheng C; Duan RQ; Quan Y; Wang KN; He YD; Xi MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):793-6. PubMed ID: 25341342
[TBL] [Abstract][Full Text] [Related]
2. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers.
Fujimoto J; Hori M; Ichigo S; Tamaya T
Invasion Metastasis; 1995; 15(5-6):203-10. PubMed ID: 8765195
[TBL] [Abstract][Full Text] [Related]
3. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
4. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
[TBL] [Abstract][Full Text] [Related]
5. Changes of Th17/Tc17 and Th17/Treg cells in endometrial carcinoma.
Zhang W; Hou F; Zhang Y; Tian Y; Jiao J; Ma D; Kong B; Cui B
Gynecol Oncol; 2014 Mar; 132(3):599-605. PubMed ID: 24388919
[TBL] [Abstract][Full Text] [Related]
6. Expression and significance of biglycan in endometrial cancer.
Liu Y; Li W; Li X; Tai Y; Lü Q; Yang N; Jiang J
Arch Gynecol Obstet; 2014 Mar; 289(3):649-55. PubMed ID: 24013431
[TBL] [Abstract][Full Text] [Related]
7. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.
Parsons LHP; Pedersen R; Richardson DL; Kho KA
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():108-112. PubMed ID: 29518640
[TBL] [Abstract][Full Text] [Related]
9. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
10. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
[TBL] [Abstract][Full Text] [Related]
11. Activation of a positive feedback loop involving IL-6 and aromatase promotes intratumoral 17β-estradiol biosynthesis in endometrial carcinoma microenvironment.
Che Q; Liu BY; Liao Y; Zhang HJ; Yang TT; He YY; Xia YH; Lu W; He XY; Chen Z; Wang FY; Wan XP
Int J Cancer; 2014 Jul; 135(2):282-94. PubMed ID: 24347287
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma.
Leitao MM; Kehoe S; Barakat RR; Alektiar K; Gattoc LP; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):244-8. PubMed ID: 18752842
[TBL] [Abstract][Full Text] [Related]
13. Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.
Fujimoto J; Sato E; Alam SM; Jahan I; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Oncology; 2006; 71(1-2):95-101. PubMed ID: 17341889
[TBL] [Abstract][Full Text] [Related]
14. The expression of interleukin-10 in patients with primary ovarian epithelial carcinoma and in ovarian carcinoma cell lines.
Zhou J; Ye F; Chen H; Lv W; Gan N
J Int Med Res; 2007; 35(3):290-300. PubMed ID: 17593856
[TBL] [Abstract][Full Text] [Related]
15. Potential clinical value of interleukin-31 and interleukin-33 with their receptors expression as diagnostic and predictive factors in endometrial cancer: a case-control study.
Zeng X; Li J; Kang LN; Xi MR; Liao GD
Int J Clin Exp Pathol; 2020; 13(6):1324-1332. PubMed ID: 32661468
[No Abstract] [Full Text] [Related]
16. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
[TBL] [Abstract][Full Text] [Related]
17. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
[TBL] [Abstract][Full Text] [Related]
18. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients.
Wang X; Huang Z; Di W; Lin Q
Arch Gynecol Obstet; 2005 Jul; 272(2):136-41. PubMed ID: 15666177
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study.
Homesley HD; Boike G; Spiegel GW
Int J Gynecol Cancer; 2004; 14(2):341-7. PubMed ID: 15086735
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significances of c-myb and Bax proteins in endometrial carcinoma].
Feng YK; Lu L; Zhang YQ; He L; Lin W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):797-800. PubMed ID: 25341343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
